Pestana Manuel, Santos Joana, Santos Alejandro, Coroas Andreia, Correia Flora, Serrão Paula, Valbuena Carmen, Soares-da-Silva Patrício
Department of Nephrology, Faculty of Medicine, Porto, Portugal.
Kidney Blood Press Res. 2004;27(2):78-87. doi: 10.1159/000076022. Epub 2004 Jan 12.
Patients with chronic glomerulonephritis exhibit salt-sensitive (SS) hypertension. In the early stage, however, the exact characteristics are still unclear. A decrease in renal dopamine production under basal conditions or after a sodium load has been reported in a subset of patients with SS primary hypertension.
The present study examined 17 untreated IgA-N patients with near-normal renal function, to determine whether salt sensitivity appears before hypertension and whether this sensitivity is related to renal dopamine production.
Daily urinary excretion of dopamine, the amine precursor--L-DOPA, and metabolites was monitored in conditions of basal sodium ingestion, followed by three consecutive 5-day periods of 100, 20 and 350 mmol/day sodium intake. The sodium sensitivity index (SSI) was evaluated in each patient. In addition, the patients were considered SS when showing an increase > or =5 mm Hg in 24-hour mean BP when they changed from a 20- to a 350-mmol/day sodium diet.
Urinary dopamine output was lower in SS than in salt-resistant patients throughout the study (p < 0.001). This was accompanied by lower creatinine clearance values and higher urinary protein excretion in SS IgA-N patients. A strong negative relationship was observed in these 17 IgA-N patients between the SSI and the daily urinary excretion of dopamine in conditions of both 20 mmol/day sodium intake (r2 = 0.592; p = 0.0003) and 350 mmol/day sodium diet (r2 = 0.352; p = 0.01). However, urinary dopamine output varied appropriately throughout the study in SS patients, in agreement with changes in sodium intake.
We conclude that in IgA-N patients, a rightward shift in the 'pressure natriuresis' can appear before hypertension and is related with a reduced renal production of dopamine. It is suggested that decreased renal dopamine synthesis in SS IgA-N patients results from acquired tubulointerstitial injury. In contrast to what has been found in SS primary hypertension, renal dopamine may behave appropriately in SS IgA-N patients, as a compensatory hormone.
慢性肾小球肾炎患者表现为盐敏感性(SS)高血压。然而,在疾病早期,确切特征仍不明确。据报道,部分SS原发性高血压患者在基础状态下或钠负荷后肾多巴胺生成减少。
本研究对17例肾功能接近正常的未经治疗的IgA肾病患者进行检查,以确定盐敏感性是否在高血压出现之前就已出现,以及这种敏感性是否与肾多巴胺生成有关。
在基础钠摄入条件下监测多巴胺、胺前体——左旋多巴及其代谢产物的每日尿排泄量,随后连续三个5天周期,钠摄入量分别为100、20和350 mmol/天。评估每位患者的钠敏感性指数(SSI)。此外,当患者从20 mmol/天钠饮食改为350 mmol/天钠饮食时,24小时平均血压升高≥5 mmHg,则被认为是盐敏感者。
在整个研究过程中,SS患者的尿多巴胺排出量低于盐抵抗患者(p<0.001)。这伴随着SS IgA肾病患者较低的肌酐清除率值和较高的尿蛋白排泄量。在这17例IgA肾病患者中,在20 mmol/天钠摄入量(r2 = 0.592;p = 0.0003)和350 mmol/天钠饮食(r2 = 0.352;p = 0.01)条件下,SSI与多巴胺每日尿排泄量之间均观察到强烈的负相关关系。然而,在整个研究过程中,SS患者的尿多巴胺排出量随钠摄入量的变化而适当变化。
我们得出结论,在IgA肾病患者中,“压力性利钠”右移可在高血压出现之前出现,且与肾多巴胺生成减少有关。提示SS IgA肾病患者肾多巴胺合成减少是由获得性肾小管间质损伤所致。与SS原发性高血压患者不同,肾多巴胺在SS IgA肾病患者中可能作为一种代偿性激素发挥适当作用。